Amgen (AMGN) PT Raised to $195 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Amgen (AMGN) PT Raised to $179 at Baird
July 27, 2018 8:48 AM EDTBaird raised its price target on Amgen (NASDAQ: AMGN) to $179.00 (from $165.00) while maintaining a Neutral rating.
... MoreAmgen (AMGN) PT Raised to $205 at Cowen Following 'Beat and Raise'
July 27, 2018 8:24 AM EDTCowen raised its price target on Amgen (NASDAQ: AMGN) to $205.00 (from $204.00) while maintaining a Outperform rating.
Analyst Phil Nadeau commented, "Amgen reported Q2 revenue of $6.06B (+4% Y/Y, vs. consensus of $5.73BE) and non-GAAP EPS of $3.83 (+17% Y/Y, vs. consensus of $3.54E). Amgen both... More
Amgen (AMGN) PT Raised to $194 at UBS
July 27, 2018 7:00 AM EDTUBS raised its price target on Amgen (NASDAQ: AMGN) to $194.00 (from $180.00) while maintaining a Neutral rating.
... MoreAmgen (AMGN) PT Raised to $210 at Piper Jaffray Following 2Q
July 27, 2018 6:45 AM EDTPiper Jaffray raised its price target on Amgen (NASDAQ: AMGN) to $210.00 (from $190.00) while maintaining a Overweight rating following the company's 2Q earnings report. AMGN posted Q218 non-GAAP EPS of $3.83, well ahead of consensus $3.55. Upside was operationally driven as revenue beat handily (total revenue was... More
Options expected to be active: EA EXPE AMGN TLT
July 27, 2018 5:17 AM EDTOptions expected to be active: EA EXPE AMGN TLT
... MoreAmgen profit beats Street view, will not raise prices again in 2018
July 26, 2018 4:16 PM EDTBy Michael Erman and Robin Respaut
(Reuters) - Amgen Inc (NASDAQ: AMGN) on Thursday reported a better-than-expected second quarter profit and raised its full-year earnings forecast, and its chief executive pledged not to raise drug prices again this year.
Amgen joined several drugmakers that have vowed to limit or delay price increases under intensifying pressure from the Trump administration to cut health care costs for U.S. consumers.
The world's largest biotechnology company also announced replacements for its head of research and development and retiring global commercial operations chief.
... MoreAmgen (AMGN) Tops Q2 EPS by 29c
July 26, 2018 4:02 PM EDTAmgen (NASDAQ: AMGN) reported Q2 EPS of $3.83, $0.29 better than the analyst estimate of $3.54. Revenue for the quarter came in at $6.06 billion versus the consensus estimate of $5.73 billion.
GUIDANCE:
Amgen sees FY2018 EPS of $13.30-$14.00, versus the consensus of $13.75. Amgen sees... More
Amgen (AMGN) call put ratio 1.42 calls to 1 put into EPS and outlook
July 26, 2018 2:29 PM EDTAmgen (NASDAQ: AMGN) July weekly call option implied volatility is at 67, August is at 23; compared to its 52-week range of 16 to 31 into the expected release of Q2 today after the market close.
... MoreAmgen (AMGN) weekly option implied volatility increases into EPS and outlook
July 26, 2018 5:19 AM EDTAmgen (NASDAQ: AMGN) July weekly call option implied volatility is at 50, August is at 28; compared to its 52-week range of 16 to 31 into the expected release of Q2 after today after the market close.
... MoreAmgen (AMGN) call put ratio 1 to 1 into Q2 and outlook
July 25, 2018 10:37 AM EDTAmgen (NASDAQ: AMGN) July weekly call option implied volatility is at 49, August is at 28; compared to its 52-week range of 16 to 31 into the expected release of Q2 after the market close on July 26.
... MoreAmgen (AMGN) weekly option implied volatility elevated into EPS and outlook
July 25, 2018 5:27 AM EDTAmgen (NASDAQ: AMGN) July weekly call option implied volatility is at 44, August is at 23; compared to its 52-week range of 16 to 31 into the expected release of Q2 after the market close on July 26.
... More